Joseph Araujo
Founder chez MINDSET PHARMA INC.
Fortune : 66 600 $ au 31/10/2023
Profil
Joseph Araujo is the founder of CanCog Technologies, Inc. (founded in 2002), Karyopharm Therapeutics, Inc. (founded in 2008), and Mindset Pharma, Inc. (founded in 2019), where he held various executive titles.
He currently holds director positions at Vivocore, Inc. and Transpharmation Ltd.
He previously served as President & Chief Executive Officer at InterVivo Solutions, Inc. from 2010 to 2023.
Mr. Araujo received an undergraduate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MINDSET PHARMA INC.
0,09% | 31/08/2023 | 90 000 ( 0,09% ) | 66 600 $ | 31/10/2023 |
Postes actifs de Joseph Araujo
| Sociétés | Poste | Début |
|---|---|---|
| MINDSET PHARMA INC. | Founder | 07/10/2019 |
CanCog Technologies, Inc.
 CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Chief Executive Officer | 01/03/2022 |
Vivocore, Inc.
 Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Director/Board Member | - |
Transpharmation Ltd.
 Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The private company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Director/Board Member | 16/09/2021 |
Anciens postes connus de Joseph Araujo
| Sociétés | Poste | Fin |
|---|---|---|
InterVivo Solutions, Inc.
 InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Chief Executive Officer | 01/03/2023 |
| KARYOPHARM THERAPEUTICS INC. | Founder | 01/09/2010 |
Formation de Joseph Araujo
| University of Toronto | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| MINDSET PHARMA INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
CanCog Technologies, Inc.
CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Commercial Services |
InterVivo Solutions, Inc.
InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Commercial Services |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Commercial Services |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The private company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Health Technology |
